Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CERUS CORP (CERS)
Standardized SEC financial data for CERUS CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001020214 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Gross margin
31.3%
Operating margin
-3.7%
Net margin
-6.7%
Revenue growth (YoY)
16.1%
Return on equity
-24.1%
ROIC
-10.6%
Free cash flow
$1.1M
Debt / equity
0.31×
Ratios for fiscal year 2025, standardized from SEC filings.